Use of Hand Carried Ultrasound, B-type Natriuretic Peptide, and Clinical Assessment in Identifying Abnormal Left Ventricular Filling Pressures in Patients Referred for Right Heart Catheterization

被引:42
|
作者
Goonewardena, Sascha N. [1 ]
Blair, John E. A. [2 ]
Manuchehry, Amin [2 ]
Brennan, J. Matthew [3 ]
Keller, Michael [2 ]
Reeves, Ryan [4 ]
Price, Adam [4 ]
Spencer, Kirk T. [4 ]
Puthumana, Jyothy [1 ]
Gheorghiade, Mihai [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Duke Univ, Durham, NC USA
[4] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
关键词
Echocardiography; hemodynamics; diagnostics; acute heart failure syndromes; DOPPLER-ECHOCARDIOGRAPHY; HIGH-RISK; FAILURE; SURVIVAL; UTILITY; BNP;
D O I
10.1016/j.cardfail.2009.08.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The estimation of left ventricular filling pressure (LVFP) remains a critical component in the management of patients with known or suspected acute heart failure syndromes. Although right heart catheterization (REIC) remains the gold standard, several noninvasive parameters, including clinical assessment. B-type natriuretic peptides (BNP), and echocardiography can approximate EVER We sought to use a combination of these measures to noninvasively predict high or low LVFP in a population referred for RHC. Methods and Results: The study consisted of validation of hand-carried ultrasound (HCU)-derived measurement of mitral E/E' against standard echocardiograms in 50 patients, as well as direct comparison of jugular venous pressure (JVP), a clinical congestion score, HCU-derived E/E' and maximum inferior vena cava diameter (IVCmax), and BNP with pulmonary capillary wedge pressure (PCWP) in another 50 patients. The mean age was 61 years, ejection fraction 40%, JVP 9 cm, BNP 948 pg/mL, IVCmax 2.1 cm, E/E' 13, and PCWP 21. All parameters performed well in determining PCWP >= 15 mm Hg, with clinical score performing the worst (area under the receiver-operator characteristic curve [AUC] 0.74), and IVCmax performing the best (AUC 0.89). JVP, in combination with HCU-derived parameters and BNP performed better than any of the individual tests alone (AUC 0.97 for combination of all 3). Conclusions: Clinical score, JVP, HCU indices, and BNP perform well at identifying patients with a PCWP >= 15 mm Hg. Use of these indices alone or in combination can be used to identify and potentially monitor patients with high LVFP in the inpatient and outpatient settings. (J Cardiac Fail 2010:16:69-75)
引用
收藏
页码:69 / 75
页数:7
相关论文
共 50 条
  • [41] Use of B-Type Natriuretic Peptide as a Screening Tool for Left Ventricular Diastolic Dysfunction in Rheumatoid Arthritis Patients Without Clinical Cardiovascular Disease
    Crowson, Cynthia S.
    Myasoedova, Elena
    Davis, John M., III
    Roger, Veronique L.
    Karon, Barry L.
    Borgeson, Daniel
    Rodeheffer, Richard J.
    Therneau, Terry M.
    Gabriel, Sherine E.
    ARTHRITIS CARE & RESEARCH, 2011, 63 (05) : 729 - 734
  • [42] Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure
    Lancellotti, Patrizio
    Cosyns, Bernard
    Pierard, Luc A.
    EUROPACE, 2008, 10 (04): : 496 - 501
  • [43] B-type natriuretic peptide is associated with both augmentation index and left ventricular mass in diabetic patients without heart failure
    Dawson, A
    Davies, JI
    Morris, AD
    Struthers, AD
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (12) : 1586 - 1591
  • [44] Right Ventricular Dysfunction and B-Type Natriuretic Peptide in Asymptomatic Patients After Repair for Tetralogy of Fallot
    Apitz, Christian
    Sieverding, Ludger
    Latus, Heiner
    Uebing, Anselm
    Schoof, Stefan
    Hofbeck, Michael
    PEDIATRIC CARDIOLOGY, 2009, 30 (07) : 898 - 904
  • [45] Right Ventricular Dysfunction and B-Type Natriuretic Peptide in Asymptomatic Patients After Repair for Tetralogy of Fallot
    Christian Apitz
    Ludger Sieverding
    Heiner Latus
    Anselm Uebing
    Stefan Schoof
    Michael Hofbeck
    Pediatric Cardiology, 2009, 30 : 898 - 904
  • [46] N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients
    Khan, Ijaz A.
    Fink, Jeffrey
    Nass, Caitlin
    Chen, Hegang
    Christenson, Robert
    deFilippi, Christopher R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10): : 1530 - 1534
  • [47] Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients
    Zeng, C.
    Wei, T.
    Jin, L.
    Wang, L.
    INTERNAL MEDICINE JOURNAL, 2006, 36 (09) : 552 - 557
  • [48] Echocardiographic and Ambulatory B-Type Natriuretic Peptide Correlates in Patients Supported By a Left Ventricular Assist Device
    Mankad, A. K.
    Raje, V. P.
    Merinar, G.
    Shah, K. B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S192 - S192
  • [49] B-type natriuretic peptide as a screening test for patients undergoing echocardiography to determine left ventricular dysfunction
    Donnelly, R
    Carl, I
    Hughes, C
    Auld, P
    Nicholls, DP
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 108 (03) : 414 - 415
  • [50] Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients
    Wei, TM
    Zeng, CL
    Chen, LP
    Chen, QY
    Zhao, RY
    Lu, GX
    Lu, CL
    Wang, LX
    EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (01) : 75 - 79